Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab

Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

(2017) Parameswaran Nair et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma

(2016) R. Sehmi et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia

(2016) Steven G. Smith et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab

(2015) Isabelle J. Pouliquen et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Importance of concomitant local and systemic eosinophilia in uncontrolled asthma

(2014) F. N. Schleich et al.   EUROPEAN RESPIRATORY JOURNAL

Anti–Interleukin-5 Monoclonal Antibody to Treat Severe Eosinophilic Asthma

(2014) Parameswaran Nair   NEW ENGLAND JOURNAL OF MEDICINE

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

(2014) Elisabeth H. Bel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

(2014) Hector G. Ortega et al.   NEW ENGLAND JOURNAL OF MEDICINE

A sensitive high throughput ELISA for human eosinophil peroxidase: A specific assay to quantify eosinophil degranulation from patient-derived sources

(2012) Sergei I. Ochkur et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

(2012) Ian D Pavord et al.   LANCET

Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

(2009) Parameswaran Nair et al.   NEW ENGLAND JOURNAL OF MEDICINE